Atenolol Tablets

Contract SPE2D2-25-D-0006 is a fixed-price award issued by the Defense Logistics Agency (DLA) Troop Support to Golden State Medical Supply, Inc. for the procurement of Atenolol tablets in 25mg, 50mg, and 100mg dosages and various bottle counts. The total award value is $8,147,325.32, covering a base year and four option years. The contract became effective on February 5, 2025, and includes a performance location in Carol Park, Queensland, Australia, with delivery terms set as FOB Destination. Modification P00002 exercised Option Year 1, effective from February 5, 2026, through February 4, 2027. The contract mandates strict adherence to federal sustainability and environmental standards, including the Resource Conservation and Recovery Act and the use of biobased or recovered materials. Packaging and marking must comply with MIL-STD-129. Administrative requirements include electronic invoicing and compliance with various DoD Class Deviations, as seen in modification P00001, which revised clauses related to equal opportunity and environmental management. The agreement also incorporates extensive cybersecurity and supply chain security provisions, including prohibitions on Kaspersky Lab and ByteDance applications, and requires compliance with NIST SP 800-171 for safeguarding covered defense information.